These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24739128)

  • 1. Costs of treatment affect compliance to specific subcutaneous immunotherapy.
    Silva D; Pereira A; Santos N; Plácido JL
    Eur Ann Allergy Clin Immunol; 2014 Mar; 46(2):87-94. PubMed ID: 24739128
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
    Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
    J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic evaluation of sublingual vs subcutaneous allergen immunotherapy.
    Pokladnikova J; Krcmova I; Vlcek J
    Ann Allergy Asthma Immunol; 2008 May; 100(5):482-9. PubMed ID: 18517082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of specific subcutaneous immunotherapy in patients with allergic rhinitis and allergic asthma.
    Brüggenjürgen B; Reinhold T; Brehler R; Laake E; Wiese G; Machate U; Willich SN
    Ann Allergy Asthma Immunol; 2008 Sep; 101(3):316-24. PubMed ID: 18814456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to Subcutaneous Allergen Immunotherapy in Southeast Turkey: A Real-Life Study.
    Tat TS
    Med Sci Monit; 2018 Dec; 24():8977-8983. PubMed ID: 30537763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to imported fire ant subcutaneous immunotherapy.
    Stokes SC; Quinn JM; Sacha JJ; White KM
    Ann Allergy Asthma Immunol; 2013 Mar; 110(3):165-7. PubMed ID: 23548525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy compliance: comparison of subcutaneous versus sublingual immunotherapy.
    Leader BA; Rotella M; Stillman L; DelGaudio JM; Patel ZM; Wise SK
    Int Forum Allergy Rhinol; 2016 May; 6(5):460-4. PubMed ID: 26718480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subcutaneous Allergen Immunotherapy in Children: Real Life Compliance and Effect of COVID-19 Pandemic on Compliance.
    Aytekin ES; Soyer Ö; Şekerel BE; Şahiner ÜM
    Int Arch Allergy Immunol; 2021; 182(7):631-636. PubMed ID: 33887728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
    Di Bona D; Plaia A; Leto-Barone MS; La Piana S; Di Lorenzo G
    J Allergy Clin Immunol; 2012 Nov; 130(5):1097-1107.e2. PubMed ID: 23021885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical efficacy and costs of the three-year specific allergen immunotherapy--retrospective study].
    Targowski T; Jahnz-Rózyk K; Przekora P; Kucharczyk A; Owczarek W
    Pol Merkur Lekarski; 2011 Aug; 31(182):106-10. PubMed ID: 21936348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous immunotherapy with aeroallergens Evaluation of adherence in real life.
    Lourenco T; Fernandes M; Coutinho C; Lopes A; Spinola Santos A; Neto M; Pereira Barbosa M
    Eur Ann Allergy Clin Immunol; 2020 Mar; 52(2):84-90. PubMed ID: 31789490
    [No Abstract]   [Full Text] [Related]  

  • 13. Economic aspects of sublingual immunotherapy.
    Incorvaia C; Ariano R; Berto P; Ciprandi G; Leo G; Boccardo R; Scurati S; Frati F
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):27-30. PubMed ID: 19944007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subcutaneous allergen immunotherapy for allergic disease: examining efficacy, safety and cost-effectiveness of current and novel formulations.
    Cox L; Calderón M; Pfaar O
    Immunotherapy; 2012 Jun; 4(6):601-16. PubMed ID: 22788128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High adherence to subcutaneous immunotherapy in a real-life study from a large tertiary medical center.
    Gelincik A; Demir S; Olgaç M; İşsever H; Khishigsuren B; Özşeker F; Çolakoğlu B; Büyüköztürk S
    Allergy Asthma Proc; 2017 Nov; 38(6):78-84. PubMed ID: 29046189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality.
    Linneberg A; Jacobsen RK; Jespersen L; Abildstrøm SZ
    J Allergy Clin Immunol; 2012 Feb; 129(2):413-9. PubMed ID: 22004944
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-adherence to subcutaneous allergen immunotherapy: inadequate health insurance coverage is the leading cause.
    Vaswani R; Garg A; Parikh L; Vaswani S
    Ann Allergy Asthma Immunol; 2015 Sep; 115(3):241-3. PubMed ID: 26195439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel approach in allergen-specific immunotherapy: combination of sublingual and subcutaneous routes.
    Keles S; Karakoc-Aydiner E; Ozen A; Izgi AG; Tevetoglu A; Akkoc T; Bahceciler NN; Barlan I
    J Allergy Clin Immunol; 2011 Oct; 128(4):808-815.e7. PubMed ID: 21641635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy.
    Hsu NM; Reisacher WR
    Int Forum Allergy Rhinol; 2012; 2(4):280-4. PubMed ID: 22434716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Compliance With Subcutaneous Immunotherapy Appointments in an Urban Tertiary Care Setting.
    Keefe KR; Ngo-Howard M; Platt MP; Brook CD
    Am J Rhinol Allergy; 2018 Nov; 32(6):473-477. PubMed ID: 30124053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.